论文部分内容阅读
目的:调查恶性肿瘤患者多重耐药菌医院感染状况,为降低和预防多重耐药菌医院感染提供参考。方法:选取医院2012年5月~2015年7月收治的800例恶性肿瘤患者为研究对象,采用回顾性方法,进行感染情况调查,筛选出多重耐药菌感染者进行进一步调查分析。结果:筛选出多重耐药菌感染的恶性肿瘤患者共120例,占15.00%;感染部位主要为呼吸道、手术创口和血液,分别占28.20%、24.50%和30.10%;分离出多重耐药菌株110种,主要为葡萄球菌属,占75.30%。结论:恶性肿瘤患者感染多重耐药菌情况严重,需采取措施预防感染,合理使用抗生素。
Objective: To investigate the status of nosocomial infections of multidrug-resistant bacteria in patients with malignant tumors and to provide reference for reducing and preventing nosocomial infections of multi-resistant bacteria. Methods: Eighty-five patients with malignant tumors admitted from May 2012 to July 2015 in our hospital were enrolled in this study. A retrospective survey was conducted to investigate the prevalence of multi-drug resistant bacteria in HIV-infected patients. Results: A total of 120 patients (15.00%) were selected from patients with multiple drug-resistant bacterial malignancies. The infected sites were mainly respiratory tract, surgical wounds and blood, accounting for 28.20%, 24.50% and 30.10% respectively. Species, mainly Staphylococcus, accounting for 75.30%. Conclusion: Patients with malignant tumors are more likely to be infected with multi-drug resistant bacteria. Measures should be taken to prevent infection and make rational use of antibiotics.